Although most sporadic CRC cases include changes in the WNT, KRAS, TGFβ, β-catenin and p53 pathways, there appears to be added complexity with additional signaling pathways showing accumulated mutations [5,6]. This evidence concerns the gene TGFB1 and colorectal carcinoma.